Search Results - noushin+niknafs+kermani

1 Results

Sort By:

Genomic Drivers of Response to Immunotherapy

Unmet NeedTumor mutational burden (TMB) is a measurement of mutations carried by tumor cells and is but one emerging biomarker for some types of cancer, including non-small cell lung cancer. Currently, there is a lack of standardization for tumor mutational burden calculation and reporting. Different tests may report different measurements, and since...

Published: 6/28/2024 | Inventor(s): Valsamo Anagnostou, Victor Velculescu, Noushin Niknafs Kermani

Keywords(s): Biomarker, Clinical Diagnostics, In Vitro Diagnostics (Old), Prognostic Biomarker, Risk Stratification

Category(s): Clinical and Disease Specializations > Immuno-Oncology, Clinical and Disease Specializations > Oncology, Technology Classifications > Diagnostics > Prognostic Biomarkers, Technology Classifications > Computers, Electronics & Software > Algorithms